A practical question before the next funding conversation
A university team preparing to turn research into a product will be asked about technical readiness and fundraising. Another question deserves equal attention: who is responsible for the next test, the first customer contract and the first employee, using whose resources and under what authority?
One person may be a researcher, a startup shareholder and a project adviser. The responsibilities attached to those roles do not automatically transfer between them. Informal understandings that work within a research group may leave a company and its partners with different expectations about availability, testing conditions and delivery.
For teams connecting Hong Kong research with Shenzhen industry, the objective is not more paperwork for its own sake. It is being able to give suppliers, customers and prospective investors a workable answer: who made this commitment, and can the team deliver it?
HKU's public guidance offers a useful starting point
The University of Hong Kong's Technology Transfer Office distinguishes disclosure from permission. Its startup declaration FAQ says a declaration does not automatically permit activities involving conflicts of interest or replace other approvals, including outside-practice approval where required. Significant changes should be reflected in an updated declaration. This is HKU guidance, not a uniform policy for every Hong Kong university. HKU startup declaration FAQ
A founder should therefore ask two separate questions: have the relevant interests been disclosed, and has this particular activity received the permissions it needs? A positive answer to the first does not settle the second.
The working checklist below is our editorial framework for discussion with the relevant department, technology transfer office and professional advisers. It is not an official HKU form or a compliance determination for a specific company.
Separate five arrangements in a responsibility record
| Discussion area | What to record | What not to assume |
|---|---|---|
| Founder time and duties | University commitments, company role, time allocation and responsible reviewer | Share ownership authorizes every operational activity |
| Laboratories and equipment | Purpose, permission route, fees, scheduling and responsibility for incidents | Previous research access means continuing free company access |
| Student participation | Voluntary involvement, tasks, compensation and separation from academic assessment | A supervisor's startup automatically has access to student labour |
| Technology and data | Rights, permitted use, confidentiality and third-party restrictions | Research authorship gives the company unrestricted commercial rights |
| External communications | Contracting entity, names and logos, and accurate descriptions of roles | A faculty member's involvement constitutes university endorsement |
The record is a way to direct questions to the right people, not an invitation for founders to make decisions on a university's behalf. For each arrangement, identify the responsible office, document version, confirmation date and event that should trigger another review. An unresolved resource question should remain unresolved in the pitch deck rather than becoming an established company asset.
Make the first customer test a bounded project
Consider a hypothetical Hong Kong research team planning a sensor test with a Shenzhen business. Everyone agrees to try the product, but access to university equipment, payment for consumables and access to the resulting data remain unclear.
Instead of relying on a broad statement of cooperation, define a small test: sample quantity, location, time window, costs, outputs and stopping conditions. The technical team specifies what can be tested. The people authorized to control equipment and data confirm what can be made available. The commercial lead specifies what the company can promise the customer.
Where a necessary permission is outstanding, include an alternative, such as an appropriately authorized external testing service or a revised scope and schedule. Access that remains subject to approval should not become an unconditional customer commitment.
This is an illustrative scenario, not a completed Jimhang Capital engagement. It does not determine whether particular data, samples or services can move across a border. Those questions require a separate review of the technology, jurisdictions and contractual arrangements involved.
Distinguish confirmed resources from coordination still required
Before fundraising, a concise status page can identify arrangements supported by written evidence, applications in progress and discussions not yet started. That is more informative than relying on a university name, a laboratory photograph and a collection of academic titles.
For example, starting a licensing discussion is not the same as holding an exclusive commercial licence. Having a professor as an adviser is not the same as having that person lead company research full-time. Chinese and English materials should retain identical qualifications: planned activity or an ongoing discussion must not become a firm commitment in translation.
Set review triggers as well. A new operating role, a different testing location, additional data or a changed student arrangement may require the team to revisit its earlier understanding. The aim is not a perfect one-time record, but a record that keeps pace with the project.
Where can Jimhang Capital contribute to the discussion?
Jimhang Capital is interested in the practical connections between Hong Kong research teams and the Greater Bay Area's industrial, entrepreneurial and venture communities. A first discussion can focus on the sequence of product validation, the need for industrial collaboration and gaps in the evidence presented for fundraising, before considering further resource introductions.
That role is distinct from university approval, legal advice or a commitment to invest. An initial approach need not contain restricted experimental data, student personal information or complete technical secrets. A non-confidential product overview, team roles, confirmed conditions and the principal unresolved question provide a useful starting point.
Contact Justin Zhan · About Jimhang Capital · Justin Zhan profile
Sources reviewed October 5, 2026. This is AI-assisted editorial analysis for Jimhang Capital's website, not a transcript of Justin Zhan's remarks, a university statement, or legal or investment advice. Institution-specific rules, permissions and cross-border matters require review by the relevant bodies and professional advisers.